NCT07266558 A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06864143 A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age Status COMPLETED Phase PHASE2
NCT06743334 Secondary Databased Post-marketing Surveillance Study of BNT162b2 Status COMPLETED Phase N/A
NCT06684379 Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) Status RECRUITING Phase PHASE1/PHASE2
NCT06610643 Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients Status NOT_YET_RECRUITING Phase NA
NCT06585241 A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations Status RECRUITING Phase PHASE4
NCT06508320 A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine) Status COMPLETED Phase PHASE2
NCT06354998 A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults Status COMPLETED Phase PHASE3
NCT06333704 Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06199934 Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data Status COMPLETED Phase N/A
NCT06167915 Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine (CHO Cell)LYB002V14 in Booster Vaccination Status NOT_YET_RECRUITING Phase PHASE1
NCT06130410 Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years Status COMPLETED Phase N/A
NCT06130345 Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran Status COMPLETED Phase N/A
NCT06127498 The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray Status UNKNOWN Phase NA
NCT06097273 A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age Status COMPLETED Phase PHASE3